Teladoc Health (TDOC) Equity Average (2015 - 2026)

Teladoc Health has disclosed Equity Average across 12 years of filings, most recently posting $1.4 billion for Q1 2026.

• Equity Average for Q1 2026 came in at $1.4 billion, down 6.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (down 6.72% YoY), and the FY2025 annual result was $1.4 billion, down 24.64% from the prior year.
• Equity Average came in at $1.4 billion for Q1 2026 at Teladoc Health, down from $1.4 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $12.6 billion in Q1 2022 to a low of $1.4 billion in Q1 2026.
• The 5-year median for Equity Average is $2.3 billion (2023), against an average of $3.2 billion.
• Across the five-year window, Equity Average tumbled 81.74% in 2023 and rose 0.35% in 2024, its largest moves.
• Teladoc Health's Equity Average stood at $4.2 billion in 2022, then tumbled by 44.74% to $2.3 billion in 2023, then tumbled by 35.09% to $1.5 billion in 2024, then dropped by 7.37% to $1.4 billion in 2025, then declined by 2.01% to $1.4 billion in 2026.
• The last three Equity Average figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.